Frovatriptan succinate is a selective agonist of the 5-HT1B and 5-HT1D receptors, exhibiting a pK50 of 8.2. This compound demonstrates greater than 10-fold selectivity for the targeted receptors compared to 5-HT1A, 5-HT1F, and 5-HT7, and over 1000-fold selectivity against various other receptors, including dopamine, histamine H1, and α1-adrenoceptors. Frovatriptan succinate is primarily utilized in migraine research, providing valuable insights into the mechanisms underlying migraine pathophysiology and potential therapeutic interventions.
Frovatriptan succinate is a selective agonist of the 5-HT1B and 5-HT1D receptors, exhibiting a pK50 of 8.2. This compound demonstrates greater than 10-fold selectivity for the targeted receptors compared to 5-HT1A, 5-HT1F, and 5-HT7, and over 1000-fold selectivity against various other receptors, including dopamine, histamine H1, and α1-adrenoceptors. Frovatriptan succinate is primarily utilized in migraine research, providing valuable insights into the mechanisms underlying migraine pathophysiology and potential therapeutic interventions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
